Hepatocellular carcinoma risk
1 paper3 findings
- Humans1
Associations
3Triglyceride
upin humans1
1 study
Triglyceride
upin humans1
Triglyceride is associated with hepatocellular carcinoma risk in humans.
“TG increased HCC risk in individuals with FLI < 60”
HumansFLI < 60; individuals without viral hepatitis
Scientific reportsOct 17, 2026
Fatty liver index
mixedin humans1
1 study
Fatty liver index
mixedin humans1
Fatty liver index predicts hepatocellular carcinoma risk in humans.
“SHAP analysis identified fatty liver index (FLI) and triglycerides (TG) as the most influential predictors.”
HumansIndividuals without viral hepatitis
Scientific reportsOct 17, 2026
Multi-Head Attention with Deep Neural Network
upin humans1
1 study
Multi-Head Attention with Deep Neural Network
upin humans1
Multi-Head Attention with Deep Neural Network predicts hepatocellular carcinoma risk in humans (AUC 0.9385, 95% CI 0.9312–0.9455; independent validation AUROC 0.8848).
“Multi-Head Attention with Deep Neural Network (MHA_DNN) achieved the highest performance”
HumansIndividuals without viral hepatitis2017–2023
Scientific reportsOct 17, 2026
Funding
1 grant since 2019National Cancer InstituteUS$268.3k
Latest
7 in 12 monthsScientific Reports
Artificial intelligence-based prediction of hepatocellular carcinoma in individuals without HBV or HCV infection in the MASLD era
Cohort study in peopleHepatocellular carcinoma
Journal of Clinical Medicine
A Multidimensional Assessment of Cardiometabolic Risk in Asian Americans with Chronic Hepatitis B Using the All of Us Datasets
Cross-sectional study of 436 peopleChronic hepatitis B
Gut and Liver
Differential Cancer Risks and Noninvasive Predictors in MASLD, MetALD, and ALD: A Longitudinal Analysis
Cohort study of 43,994 peopleCancer
International Journal of Cancer
Tibolone Use Associated With Elevated Hepatocellular Carcinoma Risk: Findings From a Nationwide Cohort
Cohort study of 117,271 peopleHepatocellular carcinoma
Journal of Gastroenterology and Hepatology
Comparable Predictive Performance of Non-VCTE-Based Machine Learning Model for HBV-Infected Hepatocellular Carcinoma Risk
Cohort study of 2,736 peopleHepatocellular carcinoma
Aging Cell
Rapamycin Reverses the Hepatic Response to Diet-Induced Metabolic Stress That Is Amplified by Aging
Experiments in miceRapamycin
Cancer Medicine
Association between telomere length and hepatocellular carcinoma risk: A Mendelian randomization study
Mendelian randomization in 472,174 peopleTelomere length
Asian Pacific Journal of Cancer Prevention
Significant SNPs Related to Telomere Length and Hepatocellular Carcinoma Risk in Chronic Hepatitis B Carriers
ReviewBiomarkers
Cancer Epidemiology
Genetic association of telomere length with hepatocellular carcinoma risk: A Mendelian randomization analysis
Study in peopleBiomarkers